chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a veterinarian refers to a her currently 14 years old daughter. On an unknown dates the patient was vaccinated with GARDASIL (she completed 3 dose series; dose, indication and route of administration were not reported). On an unknown date the patient experienced a lot of pain at injection site and in the arm of the injection after receiving GARDASIL. The mother stated when administering the third dose in the series of the GARDASIL (on an unspecified date) they had to hold her daughter down to receive the vaccine since it was so painful the last 2 times she had received it. The outcome of a lot of pain at injection site and in the arm of the injection was unknown. Relatedness between a lot of pain at injection site and in the arm of the injection and vaccination was not reported. This report is linked with MARRS # 1410USA007251 (concerning patient's sister; same reporter link). Additional information has been requested.
Dizzy, anxiety.  Drunk orange juice. Improved to normal. Left with her father. Pulse 52 SPO2 96 BP 110/60
Symptoms started  about 8:30 pm on  the evening of the vaccination.  I experienced Chills. Fever, Headache, Body Aches, Exhaustion. Symptoms continued into the following day and lasted all day long into the following evening.
Swelling, redness, non-tender, 7cm x 5cm, treated with warm compresses and Motrin.
This spontaneous report was received from a healthcare worker via company representative refers to a 86 year old male patient. On 20-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 lot # reported as K007733, expiration date: 01-MAY-2015 (dose and route of administration were not reported). Concomitant therapies included influenza virus vaccine inactivated (unspecified) which was received on the same date but was unknown which arm. On an unknown date the patient experienced very swollen right arm which was very painful after receiving PNEUMOVAX 23. Patient revisited the physician's office on 23-OCT-2014. The outcome of the events was unknown. Additional information has been requested.
One week after Comvax pt developed 4 x 4.5cm indurated, tender area with hyperpigmented center. Dad admits decreasing in size.
Reports rash and swelling noted in left deltoid.  Received 2 vaccines on 06/11/09, noticed soreness in Left arm 14 hours later. Awakened next  morning ~ 26 hours later without problems until after showering. Pt states then noticed itching and rash on left arm with soreneess at the site of one of the injections. Observed by this writer~ 27 hours urticarial rash noted around one injection site~ 7x4 cm . Skin warm to touch and client afebrile (T- oral 98.4 F. To RTC on Monday with medical provider for followup.
Had a very bad reaction from PNEUMOVAX vaccine I as not able to lift my arm from shoulder to elbow swelling and really painful 1st night chills and fever 2nd ay lethargic slept alot arm swollen and painful 3rd day starting to feel better but not great I had the PREVNAR 13 Jan 2016 no side effects hv flu shot every year no side effects just a little soreness at injection site wanted to report this grateful didn't get worse alot of joint pain as well.
pt states contracted shingles as a result of the vaccine. Pt states dx confirmed by Dr. Pt was prescribed Valtrex by MD
Numbness in the lower half of my face starting approximately 45 mins after the injection and continued for 48 hours. Migraine starting 45 minutes after the injection and continued for 48 hours. I took two extra strength Tylenol very little effect on the migraine and no relief for the numbness.
On 03/02/2021 at 03:00PM, I did not seem to have any strength and I was very sleepy. I could net get up and fix me something to eat. It lasted for about 48 hours. I did not have a fever. I just did not feel good. I did not have any strength or any energy.
extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021); arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021); redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)). At the time of the report, HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No additional AE.; PROQUAD was administered after a temperature excursion. No additional information provided. No additional AE reported. No PQC reported.    ?    Names of vaccines involved (including lot/exp) PROQUAD (W0; This spontaneous report has been received from a physician, regarding to a patient of unknown gender and age. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.   On 29-AUG-2022, the patient was vaccinated with an improperly stored dose of with improperly storage dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (rHA) (PROQUAD) injection, for prophylaxis (lot number: W017570, which was determined to be valid, with an expiration date on 29-NOV-2023) (strength, dose, vaccination scheme, route of administration, and anatomical site of injection were not reported).   Administered doses were stored at a temperature of 5.7 degrees Fahrenheit (F), during a time frame of 30 minutes (product storage error). There was a previous temperature excursion reported of 6 F up to 14 F (9.1 F) for 1 hour and 6 minutes.The administered doses of the vaccines had additional prior excursion on 18-JUL-2022, at a temperature of 6 F up to 14 F (10 F) during a time frame of 1 hour and 8 minutes.   No additional adverse events were reported in the patient.
Aphasia CVA Rhythm IRRegulaR (CardovasculaR) ElEvated Troponin
No adverse event; Vaccine was administered post expiration date 13-JUL-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered post expiration date 13-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 prophylaxis.     Patient did not describe any medical history or conditions.     On 21-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 21-Jul-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered post expiration date 13-JUL-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered post expiration date 13-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine was administered post expiration date 13-JUL-2022).    It was unknown if the patient received any other vaccine in the 4 weeks prior to COVID-19 vaccine. No previous doses were reported.  No concomitant medication was reported.   The expiration date was reported as 13-JUL-2022. Caller wanted to know what the stability of the vaccine after 13-Jun-2022.  No treatment information was reported.  This case contains information for patient 3 out of 4.   This case was linked to US-MODERNATX, INC.-MOD-2023-737010 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-737010:Master, Patient 1
Arthritis, weakening of both hands, and pain pretty much continual. Splints prescribed from late April 2000 up to now.
Pt reported large red swollen itch arm that lasted for 2 weeks after first dose.
1 hour after vaccination eyelids swelled nearly shut, red and glassy-eyed. Nausea and vomiting until 6PM 8/27/03. Mom alternated Tylenol and Motrin every 2 hours. Child missed 1st day of kindergarten.
2 am sunday morning I woke up with pain in my left wrist and hand. A blood vessel traveling through my hand and about 3 inches up my left arm felt like a rope to the touch with some swelling between my 3rd and 4th fingers. No redness or hot to the touch. Sunday morning at 9am the blood vessel returned to normal. However Sunday night at 830 pm the swelling and pain and rope like feeling of the same vein returned and the area is the same as of now  [2pm Monday the 12th of April ].
Approximately 10 hours after the administration of the shot, my son began shaking uncontrollably. He also described visual and tactile disturbances - a sort of hyper awareness as if a precursor to hallucinations - and a racing mind. The shaking and visual and tactile sensations resolved after roughly two hours. He then developed a fever of 100.8, that lasted another 4-5 hours. His symptoms resolved completely within about 14 hours of onset.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from a practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 17-NOV-2017 and 14-FEB-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N019923 and expiration date 28-APR-2019; lot# N021475 and expiration date 03-JAN-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018   was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709.
Info has been received from a certified medical assistant concerning a 12 month old male with no allergies or pertinent medical history, who on 4/4/06, was vaccinated SQ, in the left thigh with 0.5 ml dose of MMRII (lot No 650350/0970R). On 4/19/06, the pt was taken to the ER due to fever of 103.5, pulse 160 and a febrile seizure at home. It was reported that the pt also had a febrile seizure enroute to the hospital. Prior to ER, the pt had been having a runny nose and slight cough. He was given ibuprofen and acetaminophen (Tylenol) at the ER and his temperature dropped to 100.1. A CBC, BNF and blood culture were done and it was reported that the blood work was "essentially normal". On 4/21/06, the pt woke up with a rash on his head and body, no fever was present, at that time. No further info was available at the time of this report. The reporter considered the pt's experiences to be other important medical events. Additional info has been requested.
Initial report received from a non-healthcare professional on 12 JUN 2013. This case was received by Sanofi Pasteur Inc, Insurance Claims Division. A female patient, whose age, medical history and concomitant medications were not reported, had received a dose of FLUZONE High Dose (lot number, dose number, route and site of vaccination was not reported) on an unspecified date. On an unspecified date, after vaccination the patient had experienced adverse reaction (not specified). Corrective treatment and laboratory investigations were not reported. At the time of this report, the outcome of event was not reported. List of documents held by sender: none.
Constant smell of feces, started w/in 2-3 wks after 1st vaccination. H/o COVID-19 infection 12/2020
Erythematous maculopapular spots on torso, legs and arms. Not itchy. Occurred about 5 days after vaccination. Resolved without treatment. No fever.
A few hours post vax, pt broke out with a "whelpy rash" on face and trunk. No difficulty breathing, wheezing, weakness or dizziness. Mother gave 50mg Benadryl. Symptoms gone by the next morning.
-Rapid onset shortness of breath (10-20 minutes after vaccine administration).  -Required ICU admission for acute respiratory failure and acute heart failure.  -Acute reduction in ejection fraction (EF20-25%) in a patient that otherwise had a normally documented EF (>65%), see below.  -Hospital course required BiPAP and dobutamine support and treatment for pulmonary edema with Lasix.  -Cardiology consulted for acute heart failure management. Eventual wean of oxygen and dobutamine requirement and discharged on oral heart failure regimen.  -Hospital course complicated by ICU delirium.  -Total length of hospital stay 8 days
Fever greater than 100°F, localized swelling and pain at site of injection, headache, heart palpitations, tightening of chest, joint pain, fatigue, muscle aches
On 10.22.08. Pt developed (L) arm upper part papular rash. Slightly itchy. No spreading. Given VISTARIL PM.
This spontaneous report as received from a 70 year old female patient with allergy to "sulfer" refers to herself. Patient's weight was reported as: 123. On 06-JUN-2012 the patient was vaccinated with ZOSTAVAX (route, dose, lot number and exp. date not reported). Concomitant therapies included FOSAMAX and prednisone. On 25-JUN-2012 the patient experienced facial nerve pain. The pain went from her eyes down to her jaw on both sides. The pain was long term and lasted weeks and around December 2012 the pain moved its way up to the top of her head and forehead. She described it at a tight band across her head. The pain interrupted her sleep. The patient sought medical attention. She was hospitalized and Temporal Arteritis was diagnosed. The outcome of event at the time of report was unknown. Additional information has been requested.
No adverse effect reported; On 9/5/2019, one patient received an improperly stored VARlVAX; This spontaneous report was received from a registered nurse and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 05-SEP-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) injection, lot # R006221 with expiration date on 29-FEB-2020 or lot # R029517, expiration date reported as "14/2020", upon an internal verification expiration date was established on 14-OCT-2020 (exact dose, injection site and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (MERCK) injection (exact dose, injection site, route of administration, indication, lot # and expiration date were not provided). On 12-AUG-2019 and 13-AUG-2019, administered dose experienced the temperature excursions of -14 degrees Celsius to -10 degrees Celsius (-11.91 degrees Celsius, multiple) for 8 hours. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable consumer (patient) from Pfizer. A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Mar2021 (lot number and expiration date: unknown) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 25Mar2021 and subsequently tested positive for COVID on an unknown date in 2021. The patient was seeking to reschedule the appointment for the second dose. The outcome of the event was unknown.   Information on the batch/lot number has been requested.
This spontaneous report was received from a registered nurse and refers to a 4 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received on 11-OCT-2016. On 21-DEC-2016, the patient was vaccinated with an improperly stored dose of PROQUAD, lot # M023931 with expiration date of 09-NOV-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 41 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1705USA013888:
Flu-like illness; Migratory adenopathy which became generalized; Generalized arthralgia; trunk arthritis in ankles, fingers; Adenopathy, swollen joints still present 4 wks p/inject; Devel tingling, numbness in rt arm, hands;clawing rt hand;
Left thigh with 2x2cm inflammation, mild induration, non tender 2 days after vaccine given.
Fever; body chills; body aches; headache; sore arm; nausea; second dose given on 16Jan2021; This is a spontaneous report from a contactable Other HCP (patient).  This 25-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # E71686), via an unspecified route of administration, 16Jan2021 at 03:00 PM at single dose for COVID-19 immunisation. Vaccine location was Left arm. The patient was vaccinated at Health Clinic, age at vaccination was 25-years-old. Medical history and concomitant medications were unknown. Historical vaccine included first dose of BNT162B2 (Lot # EL1284), on 31Dec2020 at 01:00 PM, intramuscular. On 16Jan2021 at 04:00 PM, the patient developed fever, body chills, body aches, headache, sore arm and nausea. No treatment was received for the event. Outcome was unknown.
Swelling on upper arm and shoulder, pain Localized. Heat and anti inflammatory. Was told It would take a few days to get better.
After receiving flu vaccine, patient had circular rash around injection site and rash on left side of trunk/chest/torso. Thought it could be due to immunization or working outside in the heat.
headache, nausea, weakness, extremely sore muscles  to the point of not being able to lift objects or walk steady for 4 days. In bed the 4th day, unable to go to work & slept almost 24 hrs. due to feeling totally exhausted
Within the first 5 hours the patient experienced red eyes, nausea, fever (102 degrees F), chills, headache.
Patient received Flu vaccine and then went to leave a urine sample. Mom came and got me stating patient wasn't feeling well. When I got to patient she was standing, pale and shaking. Patient stated she felt like her throat was closing up. No difficulty breathing noted. Pulse Ox was at 100%. Took patient to exam room. Gave her some water and chocolate. Patient hadn't eaten yet. Physician went in and evaluated patient. Patient recovered quickly and was able to leave office.
Fever x now it 13 days. Myalgias, HA, rash, fatigue.
69 y.o. female that presented to my office with a 5 day history of weakness on her right side.  In particular, she states her right arm, right face, and right torso was numb when she woke up on Saturday morning, May 29th.  She initially thought she just had some radicular symptoms going down her right arm as she has had before.  However, she does admit that the facial numbness did concern her.  She had a headache that morning, but no headache after that.  She states that some of the sensation has come back a little bit in the right arm and hand.  However, she still can not hold anything without up falling out of her hand because she can not feel it.  She denies any weakness in the right side of her body.  She denies any facial droop.  She does think her vision may have gotten a little bit worse, but this is difficult to tell because she does usually have poor vision.  Because of her symptoms in the office, I thought it was best that I admit her for observation in order to rule out acute stroke.  I sent her for a stat head CT which did come back showing a subacute left-sided CVA.  Further workup is underway.  Active Hospital Problems   Diagnosis Date Noted ? Right sided numbness 06/02/2021 ? Acute cerebrovascular accident (CVA) (HCC) 06/02/2021 ? Essential hypertension 01/27/2021 ? Dyslipidemia 05/22/2017
This case was reported by a healthcare professional and described the occurrence of injection site soreness in a roughly 34-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included psoriasis. There were no concurrent medications. On 19 July 2012 the subject received 1st dose of ENGERIX B at 1 ml in the left deltoid. On 19 July 2012, immediately after vaccination with ENGERIX B, the subject experienced injection site soreness (soreness around the injection site). At the time of reporting, the injection site soreness was continuing (unresolved). The intensity was not known. It was not determined if the series would be discontinued or delayed. Attribution of the event to vaccination with ENGERIX B was not reported. It was noted that the subject was an employee at the clinic and the vaccine responsible physician was the medical director for the clinic. The lot number was reported as AHBVC047AA from the reporter; however, based on GlaxoSmithKline batch numbering the lot number was updated to AHBVC047AA.
Fever/chills ~9 hrs after second vaccine, body/muscle aches and headache all night, chills and headache  and body aches next morning
This spontaneous report as received from a nurse on 12-NOV-2014 refers to an unspecified number of patients. On unknown dates the patients were vaccinated with improperly stored doses of 0.5 ml (Oka/Merck) VARIVAX, (lot #, expiration date and route unspecified). No adverse effects reported. Additional information has been requested.
fever 101.9, pain right arm, fatigue. Had to call Oncologist and go to Acute care, IV fluids
I tested positive for COVID-19. I had a running nose, dry cough, sneezing, and fatigue. I talked to a doctor through the phone and they prescribed me PAXLOVID. I had to stop taking two of my medications because they interfered with the PAXLOVID.
Employee complains of dizziness, chills and itchy neck.  Assessment only reveals warmth at site of injection, temp of 98.2 and no redness at injection site.